It is being developed primarily as a treatment for obesity and type 2 diabetes, but its potential applications extend to several weight-related conditions including non-alcoholic fatty liver disease (NAFLD), knee osteoarthritis, and obstructive sleep apnoea
Patients who reach their maintenance dose earlier tend to see results sooner, while those with slower titration schedules experience a delayed but equally substantial endpoint
After stopping your GLP-1 medication, meet with a nutritionist to outline a successful diet maintenance plan to keep the weight off
Any combined use should involve comprehensive medical monitoring, including regular bloodwork for IGF-1, glucose, insulin, and liver enzymes
This approach prevents peptide chain breakage and preserves molecular structure
It is not like a bottle of medication sitting in a medicine cabinet